最新 Form 144 申報
公司的高階主管、董事與其他關係人要賣出受限制股票或控制股份，而且三個月內預計賣出超過 5,000 股或 5 萬美元時，下單時要交 Form 144。它是預計賣出的通知；高階主管、董事實際賣出之後，會再申報 Form 4。13D、13G 與 Form 144 是什麼
Form 144 申報
由新到舊。有 Form 144/A 修正的申報只列修正後的那一份。
近 365 天的申報（依美東日期）。
本站的 Form 144 申報：2023/1/4 到 2026/9/29。
市值明顯填錯的申報不列在這裡，也不算進合計；公司的頁面照樣列出並加註。判斷方式是把市值除以股數，得到的每股價格遠高於這家公司在預計賣出日前後的 Form 4 成交價與 13F 持股的價格，就當成填錯。
- 申報份數
- 418
- 預計賣出市值
- $14.1 億
- 賣方
- 117
- 公司
- 37
- 依 10b5-1 計畫
- 224
| 公司 | 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|---|
| ARQTArcutis Biotherapeutics, Inc. | 2025/10/115:16 ET | Howard Welgus董事 | 1.00 萬 | $18.9 萬 | 2025/10/110b5-1 | Merrill | SEC |
| VIRVir Biotechnology, Inc. | 2025/10/116:32 ET | Vicki Lee Sato董事 | 6.60 萬 | $37.7 萬 | 2025/10/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| IOTSamsara Inc. | 2025/10/116:36 ET | Dominic Phillips高階主管 | 5.56 萬 | $207.1 萬 | 2025/10/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/10/117:35 ET | Todd Franklin Watanabe高階主管 | 2.43 萬 | $46.9 萬 | 2025/10/110b5-1 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/10/216:41 ET | Larry Todd Edwards高階主管 | 4,504 | $9.03 萬 | 2025/10/2 | Merrill | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/10/216:43 ET | Todd Franklin Watanabe高階主管 | 2.07 萬 | $41.6 萬 | 2025/10/210b5-1 | Merrill Lynch | SEC |
| PTCTPTC Therapeutics, Inc. | 2025/10/316:40 ET | Boulding Mark Elliott高階主管 | 2.27 萬 | $149.1 萬 | 2025/10/310b5-1 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2025/10/317:00 ET | SVF Endurance (Cayman) Limited持股 10% 以上股東 | 166.8 萬 | $952.7 萬 | 2025/10/310b5-1 | BTIG, LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | 2025/10/616:47 ET | Herriot Tabuteau高階主管 | 1.92 萬 | $230.5 萬 | 2025/10/610b5-1 | Goldman Sachs & Co. LLC | SEC |
| PTCTPTC Therapeutics, Inc. | 2025/10/617:16 ET | Boulding Mark Elliott高階主管 | 2,266 | $14.7 萬 | 2025/10/610b5-1 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | 2025/10/716:17 ET | Boulding Mark Elliott高階主管 | 3,375 | $21.4 萬 | 2025/10/710b5-1 | Fidelity Brokerage Services LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | 2025/10/716:43 ET | Herriot Tabuteau高階主管 | 1.34 萬 | $158.9 萬 | 2025/10/710b5-1 | Goldman Sachs & Co. LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | 2025/10/816:54 ET | Herriot Tabuteau高階主管 | 1.28 萬 | $151.6 萬 | 2025/10/810b5-1 | Goldman Sachs & Co. LLC | SEC |
| EXASExact Sciences Corp | 2025/10/911:23 ET | Herriott James高階主管 | 1,500 | $9.00 萬 | 2025/10/910b5-1 | Fidelity Brokerage Services LLC | SEC |
| CLGNCollPlant Biotechnologies Ltd | 2025/10/916:55 ET | Ami Sagy股東 | 14.0 萬 | $30.8 萬 | 2025/10/10 | UBS Securities LLC | SEC |
| ARTVArtiva Biotherapeutics, Inc. | 2025/10/1716:17 ET | Fred Aslan董事 · 高階主管 | 2.55 萬 | $7.06 萬 | 2025/10/1710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| VIRVir Biotechnology, Inc. | 2025/10/2121:00 ET | SVF Endurance (Cayman) Limited持股 10% 以上股東 | 83.4 萬 | $523.0 萬 | 2025/10/2110b5-1 | BTIG, LLC | SEC |
| ZYBTZhengye Biotechnology Holding Ltd | 2025/10/2216:10 ET | Vanguards Skyline Holdings Limited股東 | 227.9 萬 | $2,942 萬 | 2025/11/1 | AC Sunshine Securities LLC | SEC |
| ZYBTZhengye Biotechnology Holding Ltd | 2025/10/2216:10 ET | VVAX Holdings Limited股東 | 68.5 萬 | $179.5 萬 | 2025/11/1 | AC Sunshine Securities LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/10/2816:06 ET | Todd F watanabe高階主管 | 4.00 萬 | $100.1 萬 | 2025/10/2810b5-1 | Merrill | SEC |
| UHSUniversal Health Services Inc | 2025/10/2916:23 ET | Elliot Sussman董事 | 965 | $21.8 萬 | 2025/10/29 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| VIRVir Biotechnology, Inc. | 2025/11/315:30 ET | de Verneuil Vanina高階主管 | 1,365 | $8,003 | 2025/11/3 | Fidelity Brokerage Services LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/11/316:52 ET | Howard Welgus董事 | 1.00 萬 | $25.3 萬 | 2025/11/310b5-1 | Merrill | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/11/317:47 ET | Patrick Burnett高階主管 | 2,622 | $6.48 萬 | 2025/11/3 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/11/317:47 ET | Todd Franklin Watanabe高階主管 | 1.15 萬 | $28.5 萬 | 2025/11/3 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/11/317:48 ET | Latha Vairavan高階主管 | 88 | $2,175 | 2025/11/3 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/11/317:49 ET | Masaru Matsuda高階主管 | 7,208 | $17.8 萬 | 2025/11/3 | Merrill Lynch | SEC |
| AXSMAxsome Therapeutics, Inc. | 2025/11/317:56 ET | Herriot Tabuteau高階主管 | 9.17 萬 | $1,245 萬 | 2025/11/310b5-1 | Goldman Sachs & Co. LLC | SEC |
| EXASExact Sciences Corp | 2025/11/410:22 ET | Herriott James高階主管 | 1,500 | $10.5 萬 | 2025/11/410b5-1 | Fidelity Brokerage Services LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | 2025/11/417:47 ET | Herriot Tabuteau高階主管 | 5.05 萬 | $680.8 萬 | 2025/11/410b5-1 | Goldman Sachs & Co. LLC | SEC |
| VIRVir Biotechnology, Inc. | 2025/11/509:47 ET | de Verneuil Vanina高階主管 | 2,385 | $1.23 萬 | 2025/11/510b5-1 | Fidelity Brokerage Services LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/11/517:29 ET | Patrick Burnett高階主管 | 3,846 | $9.12 萬 | 2025/11/510b5-1 | Merrill Lynch | SEC |
| AXSMAxsome Therapeutics, Inc. | 2025/11/519:19 ET | Herriot Tabuteau高階主管 | 2.18 萬 | $295.5 萬 | 2025/11/510b5-1 | Goldman Sachs & Co. LLC | SEC |
| MARMarriott International Inc | 2025/11/615:03 ET | Brown William P高階主管 | 6,666 | $186.7 萬 | 2025/11/6 | Wells Fargo Clearing Services | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/11/616:54 ET修正 | Todd Edwards高階主管 | 2.91 萬 | $73.3 萬 | 2025/11/6 | Merrill | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/11/617:49 ET | Patrick Burnett高階主管 | 1.73 萬 | $41.7 萬 | 2025/11/610b5-1 | Merrill Lynch | SEC |
| MARMarriott International Inc | 2025/11/710:33 ET | Breland Benjamin T.高階主管 | 1,650 | $47.2 萬 | 2025/11/7 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2025/11/711:20 ET | Reiss Rena Hozore高階主管 | 5,483 | $157.4 萬 | 2025/11/7 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2025/11/713:36 ET | Anand Satyajit高階主管 | 2,736 | $78.8 萬 | 2025/11/7 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2025/11/1011:28 ET | Roe Peggy高階主管 | 2,000 | $58.4 萬 | 2025/11/10 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2025/11/1018:48 ET | Harlan Robins高階主管 | 1.00 萬 | $14.7 萬 | 2025/11/1010b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2025/11/1018:48 ET | Chad Robins高階主管 | 8.62 萬 | $126.7 萬 | 2025/11/1010b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2025/11/1208:09 ET | Chad Robins高階主管 | 1,237 | $1.80 萬 | 2025/11/1110b5-1 | Goldman Sachs & Co. LLC | SEC |
| PBYIPuma Biotechnology, Inc. | 2025/11/1208:29 ET | Miller Michael Patrick董事 | 2.00 萬 | $9.72 萬 | 2025/11/11 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2025/11/1209:04 ET | Harrison Deborah Marriott董事 · MEMBER OF A 13D GROUP | 7.00 萬 | $2,043 萬 | 2025/11/11 | HARBOR INVESTMENT ADVISORY LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2025/11/1216:58 ET | Chad Robins高階主管 | 1,876 | $2.72 萬 | 2025/11/1210b5-1 | Goldman Sachs & Co. LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2025/11/1316:05 ET | Neha Krishnamohan董事 | 4.05 萬 | $93.9 萬 | 2025/11/1310b5-1 | Merrill | SEC |
| PTCTPTC Therapeutics, Inc. | 2025/11/1710:06 ET | Boulding Mark Elliott高階主管 | 2,812 | $21.1 萬 | 2025/11/1710b5-1 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2025/11/1715:20 ET | O'Byrne Jason高階主管 | 6,799 | $3.78 萬 | 2025/11/17 | Fidelity Brokerage Services LLC | SEC |
| ARTVArtiva Biotherapeutics, Inc. | 2025/11/1716:29 ET | Fred Aslan董事 · 高階主管 | 6,375 | $2.07 萬 | 2025/11/1710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |